Free Trial

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Stock Rated "Reduce" by Sell-Side Brokerages

DENTSPLY SIRONA logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Analysts have a consensus “Reduce” rating on DENTSPLY SIRONA: four of 14 analysts rate it sell, seven hold, and three buy. The average 12-month price target is $12.42.
  • Recent research actions included Zacks Research downgrading the stock to “strong sell,” while several firms cut price targets, including JPMorgan and BMO Capital Markets, both to $10.
  • The company missed quarterly expectations, reporting EPS of $0.29 versus $0.31 expected and revenue of $836 million versus $861.68 million expected; revenue fell 7.5% year over year.
  • MarketBeat previews top five stocks to own in December.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report) has earned a consensus rating of "Reduce" from the fourteen research firms that are covering the stock, MarketBeat reports. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating on the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $12.42.

XRAY has been the subject of several recent analyst reports. Zacks Research lowered shares of DENTSPLY SIRONA from a "hold" rating to a "strong sell" rating in a report on Monday, November 9th. Piper Sandler cut their target price on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a "neutral" rating on the stock in a research note on Friday, October 9th. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of DENTSPLY SIRONA in a research report on Friday, October 30th. JPMorgan Chase & Co. decreased their price target on DENTSPLY SIRONA from $12.00 to $10.00 and set a "neutral" rating for the company in a research note on Friday, November 6th. Finally, BMO Capital Markets lowered their price objective on DENTSPLY SIRONA from $13.00 to $10.00 and set a "market perform" rating for the company in a report on Thursday, September 17th.

Get Our Latest Analysis on DENTSPLY SIRONA

Hedge Funds Weigh In On DENTSPLY SIRONA

Several large investors have recently added to or reduced their stakes in XRAY. Bleakley Financial Group LLC boosted its holdings in DENTSPLY SIRONA by 57.1% in the third quarter. Bleakley Financial Group LLC now owns 35,451 shares of the medical instruments supplier's stock worth $314,000 after purchasing an additional 12,891 shares during the period. Gamco Investors INC. ET AL raised its holdings in shares of DENTSPLY SIRONA by 18.8% during the third quarter. Gamco Investors INC. ET AL now owns 223,515 shares of the medical instruments supplier's stock worth $1,980,000 after purchasing an additional 35,400 shares during the period. Advisors Asset Management Inc. acquired a new stake in shares of DENTSPLY SIRONA during the third quarter worth $5,168,000. Edmond DE Rothschild Holding S.A. raised its holdings in shares of DENTSPLY SIRONA by 1.4% during the third quarter. Edmond DE Rothschild Holding S.A. now owns 4,568,300 shares of the medical instruments supplier's stock worth $40,475,000 after purchasing an additional 65,000 shares during the period. Finally, Private Wealth Asset Management LLC bought a new position in shares of DENTSPLY SIRONA in the 3rd quarter worth about $103,000. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Stock Performance

NASDAQ:XRAY opened at $9.16 on Monday. The firm has a 50-day moving average of $9.43 and a two-hundred day moving average of $11.20. The company has a debt-to-equity ratio of 1.47, a current ratio of 1.63 and a quick ratio of 1.04. The stock has a market cap of $1.82 billion, a P/E ratio of -14.77, a PEG ratio of 1.34 and a beta of 0.87. DENTSPLY SIRONA has a 1-year low of $8.14 and a 1-year high of $14.76.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its earnings results on Thursday, November 5th. The medical instruments supplier reported $0.29 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.31 by ($0.02). The business had revenue of $836.00 million for the quarter, compared to analysts' expectations of $861.68 million. DENTSPLY SIRONA had a positive return on equity of 20.21% and a negative net margin of 3.38%. The firm's revenue was down 7.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.37 earnings per share. DENTSPLY SIRONA has set its FY 2026 guidance at 1.200-1.300 EPS. On average, research analysts expect that DENTSPLY SIRONA will post 1.21 earnings per share for the current fiscal year.

About DENTSPLY SIRONA

(Get Free Report)

DENTSPLY SIRONA Inc. develops, manufactures and markets products and technologies for dental professionals. Its portfolio includes dental equipment and imaging systems, digital dentistry and CAD/CAM solutions, dental implants, endodontic and restorative products, and supplies used in preventive care. The company serves dental practices, laboratories and other customers around the world. Its products support a range of clinical activities, including diagnosis, treatment planning, restorative dentistry and oral hygiene.

Featured Articles

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in DENTSPLY SIRONA Right Now?

Before you consider DENTSPLY SIRONA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.

While DENTSPLY SIRONA currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines